|
|
静脉血栓栓塞相关危险因素的研究进展
|
Abstract:
静脉血栓栓塞(VTE)是全球第三大常见死亡原因。不同国家的静脉血栓栓塞的发生率不同。在发生静脉血栓栓塞的患者中，已经发现了许多危险因素，但每个危险因素对血栓形成风险的相对贡献，以及发病机制，还没有被充分描述。本文拟就脉血栓栓塞不同危险因素的流行率、导致静脉血栓栓塞的潜在分子机制/致病介质以及VTE最常见的危险因素，包括男性、糖尿病、肥胖、吸烟、纤溶酶原激活剂抑制剂-1、口服避孕药和激素替代、癌症、抗磷脂综合征、冠状病毒2 (SARS-CoV-2)感染、轻伤和骨折、手术、怀孕进行综述。
Vous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE varies in different countries. Many risk factors have been identified in patients with VTE, but the relative contribution of each risk factor to thrombosis risk, as well as the pathogenesis, has not been fully described. This review addresses the prevalence of different risk factors for pulse thromboembolism, potential molecular mechanisms/pathogenic mediators of VTE, and the most common risk factors for VTE, including male sex, diabetes, obesity, smoking, plasminogen activator inhibitor-1, oral contraceptives and hormone replacement, cancer, coronavirus 2 (SARS-CoV-2) in-fection, minor injuries and fractures, surgery, pregnancy, antiphospholipid syndrome.
| [1] | Klemen, N.D., Feingold, P.L., Hashimoto, B., Wang, M., Kleyman, S., Brackett, A., Gross, C.P., Pei, K.Y. (2020) Mor-tality Risk Associated with Venous Thromboembolism: A Systematic Review and Bayesian Meta-Analysis. The Lancet Haematology, 7, e583-e593. https://doi.org/10.1016/S2352-3026(20)30211-8 |
| [2] | Stein, P. D., Kayali, F., Olson, R.E. and Milford, C.E. (2004) Pulmonary Thromboembolism in Asians/Pacific Islanders in the United States: Analysis of Data from the National Hospital Discharge Survey and the United States Bureau of the Census. The American Journal of Medicine, 116, 435-442. https://doi.org/10.1016/j.amjmed.2003.11.020 |
| [3] | Barco, S., Mahmoudpour, S.H., Valerio, L., Klok, F.A., Münzel, T., Middeldorp, S., Ageno, W., Cohen, A.T., Hunt, B. J., Konstantinides, S.V., et al. (2020) Trends in Mortality Related to Pulmonary Embolism in the European Region, 2000-2015: Analysis of Vital Reg-istration Data from the WHO Mortality Database. The Lancet Respiratory Medicine, 8, 277-287. https://doi.org/10.1016/S2213-2600(19)30354-6 |
| [4] | Barco, S., Woersching, A.L., Spyropoulos, A.C., Piovella, F. and Mahan, C.E. (2016) European Union-28: An Annualised Cost-of-Illness Model for Venous Thromboembolism. Thromb Haemost, 115, 800-808.
https://doi.org/10.1160/TH15-08-0670 |
| [5] | Konstantinides, S.V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.J., Harjola, V.P., Huisman, M.V., Humbert, M., Jennings, C.S., Jiménez, D., et al. (2020) 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respira-tory Society (ERS). European Heart Journal, 41, 543-603. https://doi.org/10.1093/eurheartj/ehz405 |
| [6] | Saha, P., Humphries, J., Modarai, B., Mattock, K., Waltham, M., Evans, C.E., Ahmad, A., Patel, A.S., Premaratne, S., Lyons, O.T., et al. (2011) Leukocytes and the Natural History of Deep Vein Thrombosis: Current Concepts and Future Direc-tions. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 506-512.
https://doi.org/10.1161/ATVBAHA.110.213405 |
| [7] | Piazza, G. (2015) Beyond Virchow’s Triad: Does Cardio-vascular Inflammation Explain the Recurrent Nature of Venous Thromboembolism? Vascular Medicine, 20, 102-104. https://doi.org/10.1177/1358863X14568706 |
| [8] | Mackman, N. (2012) New Insights into the Mechanisms of Ve-nous Thrombosis. Journal of Clinical Investigation, 122, 2331-2336. https://doi.org/10.1172/JCI60229 |
| [9] | Koupenova, M., Kehrel, B.E., Corkrey, H.A., Freedman, J.E. (2017) Thrombosis and Platelets: An Update. European Heart Journal, 38, 785-791. https://doi.org/10.1093/eurheartj/ehw550 |
| [10] | Savchenko, A.S., Martinod, K., Seidman, M.A., Wong, S.L., Borissoff, J.I., Piazza, G., Libby, P., Goldhaber, S.Z., Mitchell, R.N., Wagner, D.D., et al. (2014) Neutrophil Extracellu-lar Traps form Predominantly during the Organizing Stage of Human Venous Thromboembolism Development. Journal of Thrombosis and Haemostasis, 12, 860-870.
https://doi.org/10.1111/jth.12571 |
| [11] | Xu, X., Wu, Y., Xu, S., Yin, Y., Ageno, W., de Stefano, V., Zhao, Q. and Qi, X. (2022) Clinical Significance of Neutrophil Extracellular Traps Biomarkers in Thrombosis. Thrombosis Journal, 20, Article No. 63.
https://doi.org/10.1186/s12959-022-00421-y |
| [12] | Beutler, B.A. (2009) TLRs and Innate Immunity. Blood, 113, 1399-1407.
https://doi.org/10.1182/blood-2008-07-019307 |
| [13] | Fitzgerald, K.A. and Kagan, J.C. (2020) Toll-Like Receptors and the Control of Immunity. Cell, 180, 1044-1066.
https://doi.org/10.1016/j.cell.2020.02.041 |
| [14] | Heestermans, M., Poenou, G., Duchez, A.C., Hamzeh-Cognasse, H., Bertoletti, L. and Cognasse, F. (2022) Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases. International Journal of Molecular Sciences, 23, Article 13176. https://doi.org/10.3390/ijms232113176 |
| [15] | Heit, J. A., Spencer, F.A. and White, R.H. (2016) The Epidemiology of Venous Thromboembolism. Journal of Thrombosis and Thrombolysis, 41, 3-14. https://doi.org/10.1007/s11239-015-1311-6 |
| [16] | Shatzel, J. J., Connelly, K.J. and De-Loughery, T.G. (2017) Thrombotic Issues in Transgender Medicine: Areview. American Journal of Hematology, 92, 204-208. https://doi.org/10.1002/ajh.24593 |
| [17] | Elisia, I. et al. (2020) The Effect of Smoking on Chronic Inflam-mation, Immune Function and Blood Cell Composition. Scientific Reports, 10, Article No. 19480. https://doi.org/10.1038/s41598-020-76556-7 |
| [18] | Mahmoodi, B.K., et al. (2017) Association of Traditional Car-diovascular Risk Factors with Venous Thromboembolism: an Individual Participant Data Meta-Analysis of Prospective Studies. Circulation, 135, 7-16.
https://doi.org/10.1161/CIRCULATIONAHA.116.024507 |
| [19] | Bai, J., Ding, X., Du, X., Zhao, X., Wang, Z. and Ma, Z. (2015) Diabetes Is Associated with Increased Risk of Venous Thromboembolism: Asystematic Review and Me-ta-Analysis. Thrombosis Research, 135, 90-95.
https://doi.org/10.1016/j.thromres.2014.11.003 |
| [20] | Charlier, S.H.R., Meier, C., Jick, S.S., Meier, C.R. and Becker, C. (2022) Association between Glycemic Control and Risk of Venous Thromboem Bolism in Diabetic Patients: A Nested Case-Control Study. Cardiovascular Diabetology, 21, Article No. 2. https://doi.org/10.1186/s12933-021-01432-1 |
| [21] | Gariani, K., Mavrakanas, T., Combescure, C., Perrier, A. and Marti, C. (2016) Is Diabetes Mellitus a Risk Factor for Venous Thromboembolism? A Systematic Review and Me-ta-Analysis of Case-Control and Cohort Studies. European Journal of Internal Medicine, 28, 52-58. https://doi.org/10.1016/j.ejim.2015.10.001 |
| [22] | Phasha, M.N., Soma, P., Bester, J., Pretorius, E. and Phulukdaree, A. (2022) Factor XIII-A Val34Leu and Tyr204Phe Variants Influence Clot Kinetics in a Cohort of South African Type 2 Diabetes Mellitus Patients. Gene, 834, Article ID: 146637. https://doi.org/10.1016/j.gene.2022.146637 |
| [23] | Zhang, Q., Jin, Y., Li, X., Peng, X., Peng, N., Song, J. and Xu, M. (2020) Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Promoter Polymorphisms and Risk of Venous Thromboembolism—A Meta-Analysis and Systematic Review. Vasa, 49, 141-146. https://doi.org/10.1024/0301-1526/a000839 |
| [24] | Abou-Ismail, M.Y., Citla Sridhar, D. and Nayak, L. (2020) Estrogen and Thrombosis: A Bench to Bedside Review. Thrombosis Research, 192, 40-51. https://doi.org/10.1016/j.thromres.2020.05.008 |
| [25] | Kotamarti, V.S., Greige, N., Heiman, A.J., Patel, A. and Ricci, J.A. (2021) Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine, 18, 1280-1291. https://doi.org/10.1016/j.jsxm.2021.04.006 |
| [26] | Rovinski, D., Ramos, R.B., Fighera, T.M., Casanova, G.K. and Spritzer, P.M. (2018) Risk of Venous Thromboembolism Events in Post Menopausal Women Using Oral Versus Non-Oral Hormone Therapy: A Systematic Review and Meta-Analysis. Thrombosis Research, 168, 83-95. https://doi.org/10.1016/j.thromres.2018.06.014 |
| [27] | Eischer, L., Eichinger, S. and Kyrle, P.A. (2014) The Risk of Recurrence in Women with Venous Thromboembolism While Using Estrogens: A Prospective Cohort Study. Journal of Thrombosis and Haemostasis, 12, 635-640.
https://doi.org/10.1111/jth.12528 |
| [28] | Agnelli, G., Becattini, C., Bauersachs, R., Brenner, B., Campanini, M., Co-hen, A., Connors, J.M., Fontanella, A., Gussoni, G., Huisman, M.V., et al. (2018) Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study. Thromb Haemost, 118, 1668-1678.
https://doi.org/10.1055/s-0038-1668523 |
| [29] | Horsted, F., West, J. and Grainge, M.J. (2012) Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta Analysis. PLOS Medicine, 9, e1001275. https://doi.org/10.1371/journal.pmed.1001275 |
| [30] | Martens, K.L., et al. (2021) HIGH-2-LOW Risk Model to Pre-dict Venous Thromboembolism in Allogeneic Transplant Patients after Platelet Engraftment. Blood Advances, 5, 167-175. https://doi.org/10.1182/bloodadvances.2020003353 |
| [31] | Hisada, Y. and Mackman, N. (2017) Cancer-Associated Pathways and Biomarkers of Venous Thrombosis. Blood, 130, 1499-1506. https://doi.org/10.1182/blood-2017-03-743211 |
| [32] | Garcia, D. and Erkan, D. (2018) Diagnosis and Management of the Antiphospholipid Syndrome. The New England Journal of Medicine, 379, 1289-1290. https://doi.org/10.1056/NEJMc1808253 |
| [33] | Bucci, T., Menichelli, D., Pignatelli, P., Triggiani, M., Violi, F. and Pastori, D. (2019) Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review. Journal of Alzheimer’s Disease, 69, 561-576.
https://doi.org/10.3233/JAD-181294 |
| [34] | Bucci, T., Ames, P.R.J., Triggiani, M., Parente, R., Ciampa, A., Pig-natelli, P. and Pastori, D. (2022) The Multicenter ATHERO-APS Study Group. Cardiac and Vascular Features of Arteri-al and Venous Primary Antiphospholipid Syndrome. The Multicenter ATHERO-APS Study. Thrombosis Research, 209, 69-74.
https://doi.org/10.1016/j.thromres.2021.12.001 |
| [35] | Levi, M., Thachil, J., Iba, T. and Levy, J.H. (2020) Coagula-tion Abnormalities and Thrombosis in Patients with COVID-19. The Lancet Haematology, 7, e438-e440. https://doi.org/10.1016/S2352-3026(20)30145-9 |
| [36] | Burn, E., Duarte-Salles, T., Fernandez-Bertolin, S., Reyes, C., Kostka, K., Delmestri, A., Rijnbeek, P., Verhamme, K. and Prieto Alhambra, D. (2022) Venous or Arterial Thrombosis and Deaths among COVID-19 Cases: A European Network Cohort Study. The Lancet Infectious Diseases, 22, 1142-1152.
https://doi.org/10.1016/S1473-3099(22)00223-7 |
| [37] | Li, P., Zhao, W., Kaatz, S., Latack, K., Schultz, L. and Pois-son, L. (2021) Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19. JAMA Network Open, 4, e2135397.
https://doi.org/10.1001/jamanetworkopen.2021.35397 |
| [38] | Engelen, M.M., Vandenbriele, C., Balthazar, T., Claeys, E., Gunst, J., Guler, I., Jacquemin, M., Janssens, S., Lorent, N., Liesenborghs, L., et al. (2021) Venous Thromboembo-lism in Patients Discharged after COVID-19 Hospitalization. Semin Thromb Hemost, 47, 362-371. https://doi.org/10.1055/s-0041-1727284 |
| [39] | Gianni, P., Goldin, M., Ngu, S., Zafeiropoulos, S., Geropoulos, G. and Giannis, D. (2022) Complement-Mediated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19: A Review. World Journal of Experimental Medicine, 12, 53-67. https://doi.org/10.5493/wjem.v12.i4.53 |
| [40] | Tudoran, C., Velimirovici, D.E., Berceanu-Vaduva, D.M., Rada, M., Voita-Mekeres, F. and Tudoran, M. (2022) Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19. Microorganisms, 10, Article 1738. https://doi.org/10.3390/microorganisms10091738 |
| [41] | The Lancet Haematology. (2020) COVID-19 Coagulopathy: An Evolving Story. The Lancet Haematology, 7, e425.
https://doi.org/10.1016/S2352-3026(20)30151-4 |
| [42] | Violi, F., Pastori, D., Cangemi, R., Pignatelli, P. and Loffredo, L. (2020) Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost, 120, 949-956.
https://doi.org/10.1055/s-0040-1710317 |
| [43] | van Stralen, K.J., Rosendaal, F.R. and Doggen, C.J. (2008) Minor Injuries as a Risk Factor for Venous Thrombosis. Archives of Internal Medicine, 168, 21-26. https://doi.org/10.1001/archinternmed.2007.5 |
| [44] | Goualou, M., Noumegni, S., de Moreuil, C., Le Guillou, M., de Coninck, G., Hoffmann, C., Robin, S., Morcel, K., le Moigne, E., Tremouilhac, C., et al. (2022) Venous Thromboembo-lism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-Analysis. Thromb Haemost, 123, 283-294.
https://doi.org/10.1055/s-0042-1760255 |
| [45] | Scheres, L.J.J., Lijfering, W.M., Groenewegen, N.F.M., Koole, S., de Groot, C.J.M., Middeldorp, S. and Cannegieter, S.C. (2020) Hypertensive Complications of Pregnancy and Risk of Ve-nous Thromboembolism. Hypertension, 75, 781-787. https://doi.org/10.1161/HYPERTENSIONAHA.119.14280 |
| [46] | James, A.H., Rhee, E., Thames, B. and Philipp, C.S. (2014) Characterization of Antithrombin Levels in Pregnancy. Thrombosis Research, 134, 648-651. https://doi.org/10.1016/j.thromres.2014.07.025 |
